Tag: post-translational modifications in cancer

Recent advancements in cancer research have uncovered intriguing mechanisms that tumors employ to evade the immune system. One such breakthrough ...

In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled a significant advancement in understanding prostate ...

Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of ...

Fucosylation stands as a pivotal post-translational modification intricately woven into the molecular fabric of cellular biology. This biochemical process facilitates ...

In a groundbreaking study poised to reshape therapeutic strategies against pediatric liver cancer, researchers have unveiled a pivotal mechanism by ...

In the relentless search to understand cancer's evasive tactics, renal cell carcinoma (RCC), a complex kidney malignancy, stands out for ...

In a groundbreaking new study published in Nature Communications, researchers have unveiled a previously underappreciated mechanism driving the aggressive adaptability ...

In the relentless quest to unravel the complex mechanisms underlying glioblastoma—the most aggressive and lethal form of brain cancer—new research ...

In the relentless pursuit of innovative therapies addressing the formidable challenge of drug resistance, a transformative strategy has emerged from ...

Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, continues to challenge the global healthcare landscape. Despite significant advances ...